In a world where medical technology advances at an unprecedented pace, it’s the visionaries and innovators who lead the way in transforming healthcare. This year, we are honored to share that our co-founders, Martin Herman and Robert Herman, MD, have been recognized as part of the prestigious Forbes 30 Under 30 Europe 2024 list for their exceptional work in reshaping cardiovascular care.
Selected from thousands of nominations, Martin and Robert’s inclusion in this list reflects their dedication to revolutionizing cardiac diagnostics through artificial intelligence. Addressing the largest untapped market in healthcare, Powerful Medical is committed to the early detection and timely management of acute heart attacks and 38 other heart conditions. With cardiovascular diseases being the leading cause of death worldwide, our mission has the potential to significantly improve and save the lives of countless cardiac patients.
Combining cutting-edge AI with deep medical expertise, we now provide more than 35,000 healthcare professionals in 16 markets with innovative diagnostic technology, with over 30 centers of excellence in the validation process. Our certified AI-powered ECG interpretation platform, PMcardio, enables quicker and more accurate detection of heart attacks, facilitating timely intervention that can significantly improve patient outcomes.
To compile the Forbes Europe 30 Under 30 ninth annual list, Forbes’ team delved into thousands of submissions online and sought recommendations from industry insiders and previous listees. The Forbes team, alongside an independent panel of judges, including notable figures like Renzo Rosso, Simona Tabasco, and Mo Farah, evaluated candidates based on factors such as funding, revenue, social impact, scale, creativity, and future potential.
We could not have reached this milestone without the hard work and dedication of our entire team. Every day, their expertise and passion help bring our vision closer to reality. Our journey is also supported by our investors and partners, whose faith in our mission has been invaluable.
Celebrating this achievement, we also extend our congratulations to everyone recognized in this year’s Forbes 30 Under 30 list. These individuals serve as an inspiration to us and, undoubtedly, to the generations that will follow.
As we continue our journey to enter new markets, integrate PMcardio into more healthcare institutions, accumulate more clinical evidence, and develop new AI models for conditions like heart failure, the recognition by Forbes inspires us to further innovate cardiovascular care, aiming to make a meaningful impact on patient lives worldwide.
For a closer look at the Forbes 30 Under 30 Europe 2024 list and to discover more about the innovative leaders shaping our world, visit the Forbes website.
As we move forward, we remain committed to our mission of transforming cardiovascular care with AI. Together, we are setting new standards in healthcare, one diagnosis at a time. The journey ahead is promising, and we are just getting started.
Stay on the pulse with our newsletter
- Emerging ECG patterns
- Expert-led webinars
- STEMI management updates
- AI advancements in emergency hospital care
